162 related articles for article (PubMed ID: 14233312)
1. USE OF AN AMPHETAMINE-COMBINATION DRUG IN AN ANTI-OBESITY CLINIC.
BERMAN MI; ANDERSON IR
Md State Med J; 1965 Jan; 14():29-31. PubMed ID: 14233312
[No Abstract] [Full Text] [Related]
2. [ON THE DRUG THERAPY OF OBESITY].
NEUBERT D
Z Arztl Fortbild (Berl); 1965 Feb; 54():134-46. PubMed ID: 14266804
[No Abstract] [Full Text] [Related]
3. THE USES AND ABUSES OF APPETITE SUPPRESSANTS.
SEATON DA; DUNCAN LJ
Br J Clin Pract; 1965 Feb; 19():89-93. PubMed ID: 14258387
[No Abstract] [Full Text] [Related]
4. A COMPARISON OF THE APPETITE SUPPRESSING PROPERTIES OF DEXAMPHETAMINE AND PHENTERMINE.
SEATON DA; ROSE K; DUNCAN LJ
Scott Med J; 1964 Nov; 9():482-5. PubMed ID: 14231545
[No Abstract] [Full Text] [Related]
5. MANAGEMENT OF THE OBESE PATIENT: A REVIEW OF ADJUNCTIVE MEASURES.
EHRMANTRAUT WR; SAVARESE CJ
J Am Med Womens Assoc; 1964 Sep; 19():750-4. PubMed ID: 14173959
[No Abstract] [Full Text] [Related]
6. SUSTAINED-ACTION AMPHETAMINE-MEPROBAMATE COMBINATION FOR THE TREATMENT OF OBESITY.
BATTERMAN RC
Curr Ther Res Clin Exp; 1964 Jul; 6():447-53. PubMed ID: 14203275
[No Abstract] [Full Text] [Related]
7. Evaluation of amphetamine as an appetite depressant.
GALLAGHER NI; KNIGHT WA
J Chronic Dis; 1958 Aug; 8(2):244-52. PubMed ID: 13563605
[No Abstract] [Full Text] [Related]
8. Benzphetamine in the management of obesity-controlled studies.
PAVER RL
Rocky Mt Med J; 1963 Feb; 60():37-9. PubMed ID: 13942074
[No Abstract] [Full Text] [Related]
9. Use of appetite-suppressant drugs for weight reduction without dieting.
FISH CH
Clin Med (Northfield); 1962 Feb; 69():427-30. PubMed ID: 15445746
[No Abstract] [Full Text] [Related]
10. Value of ephedrine-ethlenediamine as an appetite depressant: comparison with d-amphetamine sulfate.
KUPERSMITH IH
Curr Ther Res Clin Exp; 1960 Feb; 2():39-42. PubMed ID: 14412826
[No Abstract] [Full Text] [Related]
11. A comparison of anorexigenic drugs in the treatment of the resistant obese patient.
KROGER WS
Psychosomatics; 1962; 3():454-7. PubMed ID: 14035909
[No Abstract] [Full Text] [Related]
12. Evaluation of appetite suppressants.
CASS LJ
Ann Intern Med; 1959 Dec; 51():1295-302. PubMed ID: 13808189
[No Abstract] [Full Text] [Related]
13. [Lucofene- a new anorexigenic drug for the treatment of obesity].
MUNE O; ENGBERG PALLESEN A
Ugeskr Laeger; 1960 May; 122():605-11. PubMed ID: 14425244
[No Abstract] [Full Text] [Related]
14. Psychologic factors in obesity and anorexic drugs.
KROGER WS
Am Pract Dig Treat; 1959 Dec; 10():2169-71. PubMed ID: 14412107
[No Abstract] [Full Text] [Related]
15. Control of appetite in the night eating syndrome. Successful use of an active amphetamine compound after 4:00 p.m.
BIGSBY FL; MUNIZ C
Med Times; 1963 Aug; 91():795-801. PubMed ID: 13968224
[No Abstract] [Full Text] [Related]
16. [NATRIURETIC AND DIURETIC EFFECT OF APPETITE DEPRESSANT AMPHETAMINE DERIVATIVES].
OPITZ K
Klin Wochenschr; 1965 Feb; 43():225-7. PubMed ID: 14265209
[No Abstract] [Full Text] [Related]
17. APPETITE SUPPRESSING DRUGS AS AN ETIOLOGIC FACTOR IN MENTAL ILLNESS.
BREITNER C
Psychosomatics; 1963; 4():327-33. PubMed ID: 14060673
[No Abstract] [Full Text] [Related]
18. CONTROL OF OBESITY IN THE CARDIAC PATIENT.
RUSSEK HI
Am J Med Sci; 1965 Mar; 249():305-8. PubMed ID: 14273320
[No Abstract] [Full Text] [Related]
19. N-ALICYCLIC AMPHETAMINES.
FREIFELDER M
J Med Chem; 1963 Nov; 6():813. PubMed ID: 14184960
[No Abstract] [Full Text] [Related]
20. SYMPATHOMIMETIC DRUG-INDUCED PSYCHOSIS.
MURRAY PA
J Ir Med Assoc; 1964 Jan; 54():21-3. PubMed ID: 14105269
[No Abstract] [Full Text] [Related]
[Next] [New Search]
